Quick takes: Moderna mRNA flu vaccine review, NIH award for genital herpes vaccine, malaria monoclonal antibody trial
Individuals diagnosed with multiple sclerosis (MS) often express concern about potential symptom intensification or recurrence following vaccination with live attenuated vaccines, leading to hesitancy. However, a recent investigation published in JAMA Network Open suggests that MS patients can safely receive live attenuated vaccines, specifically the measles, mumps, and rubella (MMR) and chickenpox (varicella) vaccines, without … Read more